0001358403-16-000261.txt : 20160920
0001358403-16-000261.hdr.sgml : 20160920
20160920181932
ACCESSION NUMBER: 0001358403-16-000261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160916
FILED AS OF DATE: 20160920
DATE AS OF CHANGE: 20160920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moseley Ken
CENTRAL INDEX KEY: 0001626895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 161894644
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
4
1
wf-form4_147440995943570.xml
FORM 4
X0306
4
2016-09-16
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001626895
Moseley Ken
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Sr. VP and General Counsel
Common Stock
2016-09-16
4
M
0
700
7.47
A
1044
D
Common Stock
2016-09-16
4
S
0
700
20
D
344
D
Common Stock
2016-09-19
4
M
0
1300
7.47
A
1644
D
Common Stock
2016-09-19
4
S
0
1300
20.0138
D
344
D
Common Stock
2016-09-20
4
M
0
200
7.47
A
544
D
Common Stock
2016-09-20
4
S
0
200
20
D
344
D
Stock Option (right to buy)
7.47
2016-09-16
4
M
0
700
0
D
2024-11-10
Common Stock
700.0
42417
D
Stock Option (right to buy)
7.47
2016-09-19
4
M
0
1300
0
D
2024-11-10
Common Stock
1300.0
41117
D
Stock Option (right to buy)
7.47
2016-09-20
4
M
0
200
0
D
2024-11-10
Common Stock
200.0
40917
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
25% of the shares subject to the stock option vest and become exercisable on November 11, 2015, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
/s/ Ken Moseley
2016-09-20